Citations

Clear

3942 citation(s) found for "To, Van".

Use of Calcium Phosphate Bone Cement in Retrosigmoid Craniotomies Reduces Rates of Craniotomy Site CSF Leak and Pseudomeningocele: A Cohort Study and Meta-Analysis
Bauman, Megan M., Webb, Kevin L. , Michaelcheck, Charlotte E., Link, Michael J., Celda, María Peris, Carlstrom, Lucas P. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780158 Get It

The Association of Thromboembolic Complications with the Use of Tranexamic Acid for Resection of Intracranial Meningioma
Nguyen, Brandon , Dousse, Dontre, Harris, Mark, Brown, Nolan J. , Nguyen, Andrew, Pennington, Zach , Gendreau, Julian , Dousse, Dontre', Zhang, Angie , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780144 Get It

Resection of Vestibular Schwannomas with CN VII Posterior to the Tumor: Surgical Techniques and Clinical Outcomes
Alexander, A. Yohan , Plitt, Aaron , Carlson, Matthew L. , Neff, Brian A., Driscoll, Colin L. W., Peris‐Celda, Maria , Link, Michael J. , Alexander, A Yohan , Carlstrom, Lucas P. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780093 Get It

Machine Learning-Based Model to Predict Long-Term Tumor Control and Additional Interventions following Pituitary Surgery
Atkinson, John L. D., Meyer, Fredric B. , Link, Michael J. , Pollock, Bruce E. , Celda, María Peris, Bydon, Mohamad , Davidge‐Pitts, Caroline , Erickson, Dana , Shinya, Yuki , Ghaith, Abdul Karim , Pinheiro‐Neto, Carlos , Bancos, Irina , Herndon, Justine , Bon‐Nieves, Antonio , Hong, Sukwoo , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780007 Get It

Use of Intraoperative Prolactin Levels as a Predictor for Remission in Patients with Prolactin-Secreting Adenomas
Cohen-Cohen, Salomón , Michalopoulos, Giorgos D. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780006 Get It

Unilateral versus Bilateral Approaches for Resection of Olfactory Groove Meningiomas: A Comparative Meta-analysis
Mehkri, Yusuf , Kuo, Cathleen C. , Chakravarti, Sachiv , Brown, Nolan J. , Pennington, Zach , Gendreau, Julian , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1779889 Get It

Patient‐reported outcome measure use among older adults after emergency department care: A systematic review
Gettel, Cameron J. , Galske, James , Sather, Anna, Haidous, Ali, Hwang, Ula , Brackett, Alexandria L., Venkatesh, Arjun K. , Rising, Kristin L. , Goldberg, Elizabeth M. , Oppen, James David van , Conroy, Simon , Carpenter, Christopher R , Hwang, Ula , van Oppen, James D , Venkatesh, Arjun , Goldberg, Elizabeth , Carpenter, Christopher R.

Mayo Clinic

Academic Emergency Medicine | February 17, 2024 | Volume: 31 | Issue: 3 | Pages: 273-287

10.1111/acem.14850 | PMID 38366698 Get It

AbstractBackgroundPatient‐reported outcome measures (PROMs) are gaining favor in clinical and research settings given their ability to capture a patient's symptom burden, functional status, and quality of life. Our objective in this systematic review was to summarize studies including PROMs assessed among older adults (age ≥ 65 years) after seeking emergency care.MethodsWith the assistance of a medical librarian, we searched Ovid MEDLINE, PubMed, Embase, CINAHL, Web of Science‐Core Collection, and Cochrane CENTRAL from inception through June 2023 for studies in which older adult ED patients had PROMs assessed in the post–emergency care time period. Independent reviewers performed title/abstract review, full‐text screening, data extraction, study characteristic summarization, and risk‐of‐bias (RoB) assessments.ResultsOur search strategy yielded 5153 studies of which 56 met study inclusion criteria. Within included studies, 304 unique PROM assessments were performed at varying time points after the ED visit, including 61 unique PROMs. The most commonly measured domain was physical function, assessed within the majority of studies (47/56; 84%), with measures including PROMs such as Katz activities of daily living (ADLs), instrumental ADLs, and the Barthel Index. PROMs were most frequently assessed at 1–3 months after an ED visit (113/304; 37%), greater than 6 months (91/304; 30%), and 4–6 months (88/304; 29%), with very few PROMs assessed within 1 month of the ED visit (12/304; 4%). Of the 16 interventional studies, two were determined to have a low RoB, four had moderate RoB, nine had high RoB, and one had insufficient information. Of the 40 observational studies, 10 were determined to be of good quality, 20 of moderate quality, and 10 of poor quality.ConclusionsPROM assessments among older adults following an ED visit frequently measured physical function, with very few assessments occurring within the first 1 month after an ED visit.
Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia
Peltenburg, Puck J. , Heuvel, Lieke M. van den , Kallas, Dania , Bell, Cheyanne , Denjoy, Isabelle , Behr, Elijah R. , Kammeraad, Janneke A.E. , Yap, Sing‐Chien , Probst, Vincent , Ackerman, Michael J. , Wilde, Arthur A.M. , van den Heuvel, Lieke M , Kammeraad, Janneke A E , Yap, Sing-Chien , Probst, Vincent , Ackerman, Michael J , Blom, Nico A , Wilde, Arthur A M , Clur, Sally-Ann B , van der Werf, Christian , Behr, Elijah Raphael , Denjoy, Isabelle , Peltenburg, Puck J , Field, Ella , Blom, Nico A. , Clur, Sally‐Ann B. , Werf, Christian van der

Mayo Clinic

Europace | February 13, 2024 | Volume: 26 | Issue: 2 | Pages: No page available

10.1093/europace/euae044 | PMID 38349347 Get It

Abstract Aims In patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inherited arrhythmia syndrome, arrhythmic events can be prevented by medication and lifestyle recommendations. In patients who experience breakthrough arrhythmic events, non-adherence plays an essential role. We aimed to investigate the incidence and potential reasons for non-adherence to medication and lifestyle recommendations in a large, international cohort of patients with CPVT. Methods and results An online multilingual survey was shared with CPVT patients worldwide by their cardiologists, through peer-recruitment, and on social media from November 2022 until July 2023. Self-reported non-adherence was measured using the validated Medication Adherence Rating Scale (MARS) and a newly developed questionnaire about lifestyle. Additionally, validated questionnaires were used to assess potential reasons for medication non-adherence. Two-hundred-and-eighteen patients completed the survey, of whom 200 (92%) were prescribed medication [122 (61%) female; median age 33.5 years (interquartile range: 22–50)]. One-hundred-and-three (52%) were prescribed beta-blocker and flecainide, 85 (43%) beta-blocker, and 11 (6%) flecainide. Thirty-four (17%) patients experienced a syncope, aborted cardiac arrest or appropriate implantable cardioverter defibrillator shock after diagnosis. Nineteen (13.4%) patients were exercising more than recommended. Thirty (15%) patients were non-adherent to medication. Female sex [odds ratio (OR) 3.7, 95% confidence interval (CI) 1.3–12.0, P = 0.019], flecainide monotherapy compared to combination therapy (OR 6.8, 95% CI 1.6–31.0, P = 0.010), and a higher agreement with statements regarding concerns about CPVT medication (OR 1.2, 95% CI 1.1–1.3, P < 0.001) were independently associated with non-adherence. Conclusion The significant rate of non-adherence associated with concerns regarding CPVT-related medication, emphasizes the potential for improving therapy adherence by targeted patient education.
External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis
Vaart, Thomas W. van der , Durack, David T., Karchmer, Adolf W. , Moreillon, Philippe, Selton‐Suty, Christine , Fowler, Vance G. , Meer, Jan T. M. van der, van der Vaart, Thomas W , Rasmussen, Magnus , Selton-Suty, Christine , Bossuyt, Patrick M. , Baddour, Larry M. , Bayer, Arnold S. , Durante‐Mangoni, Emanuele , Holland, Thomas L , Miró, José María , Fowler, Vance G.

Mayo Clinic

Clinical Infectious Diseases | February 8, 2024 | Volume: 78 | Issue: 4 | Pages: 922-929

10.1093/cid/ciae033 | PMID 38330166 Get It

Abstract Background The 2023 Duke–International Society of Cardiovascular Infectious Diseases (ISCVID) criteria for infective endocarditis (IE) were introduced to improve classification of IE for research and clinical purposes. External validation studies are required. Methods We studied consecutive patients with suspected IE referred to the IE team of Amsterdam University Medical Center (from October 2016 to March 2021). An international expert panel independently reviewed case summaries and assigned a final diagnosis of “IE” or “not IE,” which served as the reference standard, to which the “definite” Duke-ISCVID classifications were compared. We also evaluated accuracy when excluding cardiac surgical and pathologic data (“clinical” criteria). Finally, we compared the 2023 Duke-ISCVID with the 2000 modified Duke criteria and the 2015 and 2023 European Society of Cardiology (ESC) criteria. Results A total of 595 consecutive patients with suspected IE were included: 399 (67%) were adjudicated as having IE; 111 (19%) had prosthetic valve IE, and 48 (8%) had a cardiac implantable electronic device IE. The 2023 Duke-ISCVID criteria were more sensitive than either the modified Duke or 2015 ESC criteria (84.2% vs 74.9% and 80%, respectively; P < .001) without significant loss of specificity. The 2023 Duke-ISCVID criteria were similarly sensitive but more specific than the 2023 ESC criteria (94% vs 82%; P < .001). The same pattern was seen for the clinical criteria (excluding surgical/pathologic results). New modifications in the 2023 Duke-ISCVID criteria related to “major microbiological” and “imaging” criteria had the most impact. Conclusions The 2023 Duke-ISCVID criteria represent a significant advance in the diagnostic classification of patients with suspected IE.